MY185184A - Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains - Google Patents

Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains

Info

Publication number
MY185184A
MY185184A MYPI2015001671A MYPI2015001671A MY185184A MY 185184 A MY185184 A MY 185184A MY PI2015001671 A MYPI2015001671 A MY PI2015001671A MY PI2015001671 A MYPI2015001671 A MY PI2015001671A MY 185184 A MY185184 A MY 185184A
Authority
MY
Malaysia
Prior art keywords
cold
temperature sensitive
strains
adapted temperature
enterovirus
Prior art date
Application number
MYPI2015001671A
Inventor
Kaw Bing Chua
Original Assignee
Temasek Life Sciences Laboratory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temasek Life Sciences Laboratory Ltd filed Critical Temasek Life Sciences Laboratory Ltd
Publication of MY185184A publication Critical patent/MY185184A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to cold-adapted temperature sensitive Enterovirus 71 strains, particularly to the cold-adapted temperature sensitive Enterovirus 71 strains EV71:TLLfJP20 and EV71:TLLaP20. The present invention also relates to processes of developing the cold-adapted temperature sensitive virus strains.
MYPI2015001671A 2013-01-18 2013-01-18 Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains MY185184A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG2013/000027 WO2014112945A1 (en) 2013-01-18 2013-01-18 Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains

Publications (1)

Publication Number Publication Date
MY185184A true MY185184A (en) 2021-04-30

Family

ID=51209913

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2015001671A MY185184A (en) 2013-01-18 2013-01-18 Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains

Country Status (6)

Country Link
JP (1) JP6117379B2 (en)
CN (1) CN104918636B (en)
MY (1) MY185184A (en)
SG (1) SG11201505468VA (en)
TW (1) TWI705140B (en)
WO (1) WO2014112945A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106795499B (en) * 2014-06-12 2021-05-14 淡马锡生命科学研究院有限公司 Development of stable cold-adapted temperature-sensitive chimeric enteroviruses
AR102548A1 (en) 2014-11-07 2017-03-08 Takeda Vaccines Inc VACCINES AGAINST HAND, FEET AND MOUTH DISEASE AND MANUFACTURING AND USE METHODS
MA40920A (en) 2014-11-07 2017-09-12 Takeda Vaccines Inc VACCINES OF THE HAND, FOOT AND MOUTH, AND METHODS OF MANUFACTURING AND USE THEREOF
MA41506A (en) * 2015-02-13 2017-12-19 Takeda Vaccines Inc VIRUS PRODUCTION PROCESSES TO PRODUCE VACCINES
CN109504662B (en) * 2018-11-09 2022-06-10 浙江天元生物药业有限公司 Coxsackie virus attenuated strain and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7150984B2 (en) * 1994-07-11 2006-12-19 The United States Of America As Represented By The Department Of Health And Human Services Attenuated human rotavirus vaccine
KR20040094881A (en) * 1998-09-01 2004-11-10 세인트 루이스 유니버시티 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus

Also Published As

Publication number Publication date
WO2014112945A1 (en) 2014-07-24
TW201522642A (en) 2015-06-16
TWI705140B (en) 2020-09-21
JP2016511634A (en) 2016-04-21
CN104918636A (en) 2015-09-16
CN104918636B (en) 2018-06-26
HK1213474A1 (en) 2016-07-08
JP6117379B2 (en) 2017-04-19
SG11201505468VA (en) 2015-08-28

Similar Documents

Publication Publication Date Title
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
MX2018012880A (en) Methods for providing single-stranded rna.
NZ733055A (en) Anti-c10orf54 antibodies and uses thereof
MX377710B (en) MONOCLONAL ANTIBODIES AGAINST BCMA.
CL2016002455A1 (en) Multispecific antibodies.
PH12016501143A1 (en) Anti-cd33 antibodies and immunoconjugates
MX2018010295A (en) Antibodies having specificity for btla and uses thereof.
GEP20176808B (en) Fused heterocyclic compound
MX2016003129A (en) Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1.
MY205583A (en) Acid-alpha glucosidase variants and uses thereof
PH12016501873A1 (en) Anti-influenza b virus hemagglutinin antibodies and methods of use
MX2015006324A (en) Methods for the manufacture of proteolytically processed polypeptides.
TR201900124T4 (en) Dispersion Resins
MX2021004464A (en) Thiazolide compounds for treating viral infections.
MX376962B (en) NEW MACROCYCLIC COMPOUNDS.
MX2015011837A (en) Co-crystals of pyrimethanil and selected dithiine tetracarboximide.
EA201600026A1 (en) BACTERIAL HYALURONIDASE AND METHOD FOR ITS PRODUCTION
MX2016002027A (en) Novel anti-fc-gamma receptor iib antibodies and uses thereof.
MY185184A (en) Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains
IN2013CH05383A (en)
MX2016007884A (en) Biomarkers for hbv treatment response.
MX2021015198A (en) Artificially activated toxic peptides.
MX2015010789A (en) Anti-mcsp antibodies.
IN2013CH05865A (en)
JP2014212868A5 (en)